Search results

Results 1 - 10 of 75

Customise shown information

Export selection Export all

Case C-762/21 P: Appeal brought on 10 December 2021 by St. Hippolyt Holding GmbH against the judgment of the General Court (Tenth Chamber) delivered on 20 October 2021 in Case T-352/20, St. Hippolyt v EUIPO — Elephant

OJ C 237, 20/06/2022, p. 23–23 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 237, 20/06/2022, p. 23–23

CELEX number:: 62021CN0762
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: Court of Justice
Date of document:: 10/12/2021
Number of pages:: 1

pdf
html

Amendments adopted by the European Parliament on 8 July 2021 on the proposal for a regulation of the European Parliament and of the Council on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (COM(2020)0725) — C9-0365/2020 — 2020/0321(COD))

OJ C 99, 01/03/2022, p. 252–312 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 99, 01/03/2022, p. 252–312

CELEX number:: 52021AP0351
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Legislative resolution

Author:: European Parliament, Committee on Budgets, Committee on Industry, Research and Energy, Committee on the Environment, Public Health and Food Safety, Committee on the Internal Market and Consumer Protection
Date of document:: 08/07/2021; Date of vote
Number of pages:: 61

pdf
html

Case T-194/21: Judgment of the General Court of 21 December 2021 — Fidia farmaceutici v EUIPO — Stelis Biopharma (HYALOSTEL ONE) (EU trade mark — Opposition proceedings — International figurative registration designating the European Union — Figurative mark HYALOSTEL ONE — Earlier EU word mark HYALISTIL and earlier figurative mark HyalOne — Earlier international word mark HYALO — Relative ground for refusal — Article 8(1)(b) of Regulation (EU) 2017/1001 — Obligation to state reasons)

OJ C 95, 28/02/2022, p. 33–33 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
OJ C 95, 28/02/2022, p. 11–11 (GA)

OJ C 95, 28/02/2022, p. 33–33

CELEX number:: 62021TA0194
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 21/12/2021
Number of pages:: 1

pdf
html

Case T-787/21: Action brought on 21 December 2021 — UniSkin v EUIPO — Unicskin (UNISKIN by Dr. Søren Frankild)

OJ C 73, 14/02/2022, p. 57–57 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
OJ C 73, 14/02/2022, p. 16–16 (GA)

OJ C 73, 14/02/2022, p. 57–57

CELEX number:: 62021TN0787
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 21/12/2021
Number of pages:: 1

pdf
html

Case C-702/21 P: Appeal brought on 19 November 2021 by Laboratoire Pareva against the judgment of the General Court (Seventh Chamber) delivered on 15 September 2021 in Joined Cases T-337/18 and T-347/18, Laboratoire Pareva and Biotech3D v Commission

OJ C 64, 07/02/2022, p. 18–19 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 64, 07/02/2022, p. 18–19

CELEX number:: 62021CN0702
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: Court of Justice
Date of document:: 19/11/2021
Number of pages:: 2

pdf
html

Case T-644/21: Action brought on 4 October 2021 — Pharmadom v EUIPO — Wellbe Pharmaceuticals (WellBe PHARMACEUTICALS)

OJ C 37, 24/01/2022, p. 35–35 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 37, 24/01/2022, p. 35–35

CELEX number:: 62021TN0644
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 04/10/2021
Number of pages:: 1

pdf
html

Case T-681/21: Action brought on 20 October 2021 — Alves Casas v EUIPO — Make-Up Art Cosmetics (mccosmetics NY)

OJ C 2, 03/01/2022, p. 43–43 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 2, 03/01/2022, p. 43–43

CELEX number:: 62021TN0681
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 20/10/2021
Number of pages:: 1

pdf
html

Case T-248/20: Judgment of the General Court of 10 November 2021 — Stada Arzneimittel v EUIPO — Pfizer (RUXYMLA) (EU trade mark — Opposition proceedings — Application for the EU word mark RUXYMLA — Earlier EU word mark RUXIMERA — Relative ground for refusal — Likelihood of confusion — Similarity of the signs — Article 8(1)(b) of Regulation (EU) 2017/1001)

OJ C 2, 03/01/2022, p. 30–31 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 2, 03/01/2022, p. 30–31

CELEX number:: 62020TA0248
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 10/11/2021
Number of pages:: 2

pdf
html

Case T-239/20: Judgment of the General Court of 10 November 2021 — Stada Arzneimittel v EUIPO — Pfizer (RUXXIMLA) (EU trade mark — Opposition proceedings — Application for the EU word mark RUXXIMLA — Earlier EU word mark RUXIMERA — Relative ground for refusal — Likelihood of confusion — Similarity of the signs — Article 8(1)(b) of Regulation (EU) 2017/1001)

OJ C 2, 03/01/2022, p. 30–30 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 2, 03/01/2022, p. 30–30

CELEX number:: 62020TA0239
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 10/11/2021
Number of pages:: 1

pdf
html

Case T-542/20: Judgment of the General Court of 10 November 2021 — Stada Arzneimittel v EUIPO — Pfizer (RUXIMBLIS) (EU trade mark — Opposition proceedings — Application for the EU word mark RUXIMBLIS — Earlier EU word mark RUXIMERA — Relative ground for refusal — Likelihood of confusion — Similarity of the signs — Article 8(1)(b) of Regulation (EU) 2017/1001)

OJ C 2, 03/01/2022, p. 33–33 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 2, 03/01/2022, p. 33–33

CELEX number:: 62020TA0542
Languages:: BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV
Form:: Judicial information

Author:: General Court
Date of document:: 10/11/2021
Number of pages:: 1

pdf
html

Results 1 - 10 of 75

Clear selection

Customise shown information

Export selection Export all

Domain: All, EUROVOC descriptor: pharmaceutical product, Date of document: 2021, Search language: English

Search criteria